Drugs / Isotonix OPC-3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00331227 | May → Dec 2006 | — | Wake Forest University Health Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isotonix OPC-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00331227 ↗ |
| Known as | OPC-3 | “We propose to use a supplement made by NutraMetrix (called OPC-3), consisting of oligomeric proanthocyanidins derived from grape seed, pine bark, bilberry, citrus and red wine...” NCT00331227 ↗ |
| Modality | Other / unclassified | “Isotonix OPC-3 (flavonoid supplement)” NCT00331227 ↗ |